Back

Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms 5 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Shakhnoza Mukhtarova

Tashkent Pediatric Medical Institute, Tashkent (Uzbekistan)

5 More presentations in this session

Presentation thumbnail
Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
Doctor S. Mukhtarova (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Impact of HFpEF in pacemaker patients: a closer look at heart failure events and mortality risk
Mrs E. Santos (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Unraveling gender's influence: a detailed analysis of mortality and acute heart failure risk in HFpEF Patients post-pacemaker Implantation
Miss E. Santos (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Cardiopulmonary exercise testing in HFpEF patients - a stress-to-rest ratio analyses
Doctor K. Franz (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Usefulness of the H2PEF score in the stratification of patients with a diagnosis of heart failure with preserved ejection fraction in primary care
Miss V. Cendros (ES)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
thumbnail
Congress Presentation
Prognostic value of quantitative anatomical and functional measures of coronary artery disease in diabetic and non-diabetic patients
thumbnail
Congress Presentation
Impact of impaired glucose metabolism on coronary atherosclerosis in patients with very low LDL cholesterol: a potential framework to understand residual risk in chronic coronary syndromes.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources